Management of Nocturnal Enuresis
First-Line Treatment Approach
For uncomplicated monosymptomatic nocturnal enuresis in children, begin with supportive behavioral interventions, then advance to either enuresis alarm therapy (most effective long-term) or desmopressin (most convenient), with alarm therapy preferred when family commitment is adequate. 1, 2
Initial Assessment Requirements
Before initiating treatment, the evaluation must identify specific conditions requiring immediate specialized referral or targeted therapy:
Mandatory Urologic Referral 3, 2
- Daytime wetting with abnormal voiding patterns (unusual posturing, straining, weak stream)
- History of recurrent urinary tract infections
- Genital abnormalities on examination
- Continuous incontinence or need for abdominal pressure to void
Treat Underlying Conditions First 3, 1, 2
- Constipation/fecal impaction: Disimpaction and bowel regimen with polyethylene glycol often eliminates enuresis through relieving mechanical bladder pressure
- Sleep apnea: Enlarged tonsils/adenoids with snoring warrant ENT evaluation; surgical correction can cure enuresis
- Psychological stressors: Secondary enuresis following divorce, trauma, abuse, or hospitalization requires crisis intervention or psychotherapy
Essential Baseline Data 3
- Two-week diary documenting wet/dry nights
- Urinalysis (urine culture only if infection suspected)
- First-morning specific gravity (predicts desmopressin response)
- Frequency-volume chart to assess voiding patterns
Supportive Behavioral Interventions (Always Implement)
These foundational strategies should be applied universally, though evidence for efficacy is limited 3, 1, 2:
- Education: Explain high prevalence (7-10% at age 8), spontaneous cure rate (14-16% annually), and involuntary nature to prevent punishment 3
- Regular voiding schedule: Void at consistent intervals during day, always at bedtime and upon awakening 1, 4
- Fluid management: Liberal water intake morning/early afternoon; restrict evening fluids and eliminate caffeinated beverages before bed 3, 1
- Dry bed charts: Child maintains journal and participates in changing bedding for consciousness-raising 3, 2
- Physical activity: Encourage regular exercise 1
Definitive Treatment Options
Enuresis Alarm Therapy (Preferred First-Line)
Conditioning therapy achieves 66% initial success with sustained long-term cure in over half of patients, superior to all pharmacologic options for durability. 3, 1, 4
Implementation Requirements 3, 2
- Use modern portable body-worn alarms (not bell-and-pad systems)
- Provide written contract and thorough instructions
- Schedule monitoring appointments every 3 weeks minimum
- Ensure adequate parental commitment to awaken child initially (most common failure point)
- Continue with overlearning protocol: alternate-day use before discontinuation
- Children with most frequent enuresis respond best
Contraindications to Alarm Therapy 3
- Inadequate sleeping arrangements
- Insufficient family support or reliability
- Inability of adults to monitor consistently
Desmopressin (Alternative First-Line)
Desmopressin is the pharmacologic agent of choice, achieving 30% complete response and 40% partial response, most effective for children with documented nocturnal polyuria. 1, 4, 2
Patient Selection Criteria 1, 2
- Nocturnal urine production >130% of expected bladder capacity for age
- Maximum voided volume >70% of expected bladder capacity (normal reservoir function)
- Alarm therapy failed or compliance unlikely
- Absolute contraindication: Polydipsia
Dosing Protocols 1, 4, 5
- Oral tablets: 0.2-0.4 mg taken at least 1 hour before sleep
- Oral melt tablets: 120-240 μg taken 30-60 minutes before bedtime
- Avoid nasal spray formulations (higher hyponatremia risk)
Critical Safety Measures 1, 4, 2
- Mandatory fluid restriction: Evening intake ≤200 ml (6 ounces), no drinking until morning
- Warning: Desmopressin plus excessive fluids causes water intoxication, hyponatremia, and convulsions
- Schedule regular drug holidays to reassess continued need
Treatment-Resistant Cases
Re-evaluation Steps 2, 6
- Confirm monosymptomatic classification (exclude undetected daytime symptoms)
- Verify desmopressin administration method and fluid restriction compliance
- Assess fundamental suitability for alarm therapy if used
Second-Line Pharmacologic Options
Anticholinergic Medications 4, 2, 7
- Consider when desmopressin ineffective or contraindicated
- Particularly useful with evidence of detrusor overactivity
- Options: oxybutynin, tolterodine, propiverine
Combination Therapy 2, 6
- Desmopressin plus anticholinergic agent more effective than desmopressin alone
- Reserve for documented treatment failures
Imipramine (Historical Alternative) 4, 2, 5
- Effectiveness 40-60% but higher relapse rates than desmopressin
- Pediatric dosing: Start 25 mg one hour before bedtime (age ≥6 years); increase to 50 mg if no response in one week (under age 12) or 75 mg (over age 12)
- Maximum dose: 2.5 mg/kg/day; doses >75 mg increase side effects without enhancing efficacy
- Early-night bedwetters may benefit from divided dosing (25 mg mid-afternoon, repeated at bedtime)
- Taper gradually when discontinuing
Adult Nocturnal Enuresis
Desmopressin remains the drug of choice for adults with nocturnal enuresis, particularly when associated with nocturnal polyuria. 4
The treatment algorithm mirrors pediatric management with identical dosing, safety precautions, and consideration of alarm therapy (66% success rate) as alternative or adjunct 4. Address underlying sleep disorders, particularly sleep apnea, and treat constipation if present 4.
Common Pitfalls
- Ineffective interventions lacking evidence: Bladder-stretching exercises, hypnotherapy, dietary manipulation, allergen desensitization 3, 2
- Punishment or control struggles: Worsen outcomes and cause psychological harm 3
- Premature treatment: Not all children require intervention; many families appropriately choose watchful waiting given 14-16% annual spontaneous resolution 3
- Inadequate alarm therapy support: Failure to awaken child initially is primary reason for treatment failure 3